On Automation in Anesthesia

The thesis discusses closed-loop control of the hypnotic and the analgesic components of anesthesia. The objective of the work has been to develop a system which independently controls the intravenous infusion rates of the hypnotic drug propofol and analgesic drug remifentanil. The system is designed to track a reference hypnotic depth level, while maintaining adequate analgesia. This is complicated by inter-patient variability in drug sensitivity, disturbances caused foremost by surgical stimulation, and measurement noise. A commercially available monitor is used to measure the hypnotic depth of the patient, while a simple soft sensor estimates the analgesic depth. Both induction and maintenance of anesthesia are closed-loop controlled, using a PID controller for propofol and a P controller for remifentanil. In order to tune the controllers, patient models have been identified from clinical data, with body mass as only biometric parameter. Care has been taken to characterize identifiability and produce models which are safe for the intended application. A scheme for individualizing the controller tuning upon completion of the induction phase of anesthesia is proposed. Practical aspects such as integrator anti-windup and loss of the measurement signal are explicitly addressed. The validity of the performance measures, most commonly reported in closed-loop anesthesia studies, is debated and a new set of measures is proposed. It is shown, both in simulation and clinically, that PID control provides a viable approach. Both results from simulations and clinical trials are presented. These results suggest that closed-loop controlled anesthesia can be provided in a safe and efficient manner, relieving the regulatory and server controller role of the anesthesiologist. However, outlier patient dynamics, unmeasurable disturbances and scenarios which are not considered in the controller synthesis, urge the presence of an anesthesiologist. Closed-loop controlled anesthesia should therefore not be viewed as a replacement of human expertise, but rather as a tool, similar to the cruise controller of a car

A FRAMEWORK FOR CREDIBILITY ASSESSMENT OF SUBJECT-SPECIFIC PHYSIOLOGICAL MODELS

Physiological closed-loop controllers and decision support systems are medical devices that enable some degree of automation to meet the needs of patients in resource-limited environments such as critical care and surgical units. Traditional methods of safety and effectiveness evidence generation such as pre-clinical animal and human clinical studies are cost prohibitive and may not fully capture different performance attributes of such complex safety-criticalsystems primarily due to subject variability. In silico studies using subject-specific physiological models (SSPMs) may provide a versatile platform to generate pre-clinical and clinical safety evidence for medical devices and help reduce the size and scope of animal studies and/or clinical trials. To achieve such a goal, the credibility of the SSPMs must be established for the purpose it is intended to serve. While in the past decades significant research has been dedicated towards development oftools and methods for development and evaluation of SSPMs, adoption of such models remains limited, partly due to lack of trust in SSPMs for safety-critical applications. This may be due to a lack of a cohesive and disciplined credibility assessment framework for SSPMs. In this dissertation a novel framework is proposed for credibility assessment of SSPMs. The framework combines various credibility activities in a unified manner to avoid or reduce resource intensive steps, effectively identify model or data limitations, provide direction as to how to address potential model weaknesses, and provide much needed transparency in the model evaluation process to the decision-makers. To identify various credibility activities, the framework is informed by an extensive literature review of more mature modeling spaces focusing on non- SSPMs as well as a literature review identifying gaps in the published work related to SSPMs. The utility of the proposed framework is successfully demonstrated by its application towards credibility assessment of a CO2 ventilatory gas exchange model intended to predict physiological parameters, and a blood volume kinetic model intended to predict changes in blood volume inresponse to fluid resuscitation and hemorrhage. The proposed framework facilitates development of more reliable SSPMs and will result in increased adoption of such models to be used for evaluation of safety-critical medical devices such as Clinical Decision Support (CDS) and Physiological Closed-Loop Controlled (PCLC) systems